In a triple-blind, placebo-controlled 30-week clinical study involving patients with T2DM with a BMI of 33 6 kg/m 2 , it was found that the weight loss in the EX treatment group was significantly higher than that in the control group
GLP-1 medicationsincluding household names like Ozempic, Wegovy, Byetta, and Victozamimic a natural hormone your gut produces after eating, called GLP-1 (short for glucagon-like peptide-1)
Defended by the Sikiric group on the basis of gastric stability data
Excess B12 is excreted through urine as a water-soluble vitamin, reducing the risk of toxicity
Jolynn Tumolo Neurology | July 22, 2026 SGLT2 inhibitor use was linked to a lower risk for dementia among older adults with psychiatric disorders
Titration Schedule : Starts with a lower dose, gradually increased over weeks